Previous studies determined that IL6 signalling in gliomas acted as a key regulator of the immunosuppressive microenvironment and was an important promoter of proliferation, survival and invasiveness of tumour cells [27–30]. The gene discussed is IL6; the disease is central nervous system cancer.